Louisiana Oysters Linked to Deadly Vibrio Outbreak, Officials Warn
So far in 2025, there have been 34 confirmed infections and six deaths linked to Vibrio vulnificus in Louisiana
FDA Approves Updated COVID Vaccines, but Fewer People Will Be Eligible
People 65 or older or with an underlying health condition will likely still be eligible for the new vaccine
FDA Urges Safe Use of Hyperbaric Oxygen Therapy Devices
Agency is reminding health care providers to carefully follow the manufacturer's instructions
U.S. Resident Diagnosed With Rare Screwworm Parasite After Travel
29 Percent of Infants Immunized Against RSV in 2023 to 2024 Season
Infant RSV immunization coverage through nirsevimab or maternal vaccination ranged from an estimated 11 to 53 percent by state
NYC Legionnaires’ Outbreak: 6 Deaths, 112 Cases
FDA Suspends U.S. License of Chikungunya Vaccine
Ixchiq has been linked to more than 20 serious adverse events resembling chikungunya illness
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis
Papzimeos is the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis
